Grucza R, Pekkarinen H, Titov E K, Kononoff A, Hänninen O
Department of Applied Physiology, Medical Research Centre, Polish Academy of Sciences, Warsaw.
Eur J Appl Physiol Occup Physiol. 1993;67(3):279-85. doi: 10.1007/BF00864229.
Thermoregulatory responses to exercise in relation to the phase of the menstrual cycle were studied in ten women taking oral contraceptives (P) and in ten women not taking oral contraceptives (NP). Each subject was tested for maximal aerobic capacity (VO2max) and for 50% VO2max exercise in the follicular (F) and luteal (L) phases of the menstrual cycle. Since the oral contraceptives would have prevented ovulation a quasi-follicular phase (q-F) and a quasi-luteal phase (q-L) of the menstrual cycle were assumed for P subjects. Exercise was performed on a cycle ergometer at an ambient temperature of 24 degrees C and relative air humidity of 50%. Rectal (Tre), mean skin (Tsk), mean body (Tb) temperatures and heart rate (fc) were measured. Sweat rate was estimated by the continuous measurement of relative humidity of air in a ventilated capsule placed on the chest, converted to absolute pressure (PH2Ochest). Gain for sweating was calculated as a ratio of increase in PH2Ochest to the appropriate increase in Tre for the whole period of sweating (G) and for unsteady-state (Gu) separately. The VO2max did not differ either between the groups of subjects or between the phases of the menstrual cycle. In P, rectal temperature threshold for sweating (Tre,td) was 37.85 degrees C in q-L and 37.60 degrees C in q-F (P < 0.01) and corresponded to a significant difference from Tre at rest. The Tre, Tsk, Tb and fc increased similarly during exercise in q-F and q-L. No menstrual phase-related differences were observed either in the dynamics of sweating or in G.(ABSTRACT TRUNCATED AT 250 WORDS)
研究了10名服用口服避孕药的女性(P组)和10名未服用口服避孕药的女性(NP组)在月经周期各阶段对运动的体温调节反应。对每位受试者在月经周期的卵泡期(F)和黄体期(L)进行最大有氧能力(VO2max)测试以及50%VO2max运动测试。由于口服避孕药会抑制排卵,因此假定P组受试者月经周期存在准卵泡期(q-F)和准黄体期(q-L)。运动在环境温度24摄氏度、相对空气湿度50%的周期测力计上进行。测量直肠温度(Tre)、平均皮肤温度(Tsk)、平均体温(Tb)和心率(fc)。通过连续测量置于胸部的通风胶囊内空气的相对湿度来估算出汗率,将其转换为绝对压力(PH2Ochest)。分别计算整个出汗期(G)和非稳态(Gu)时出汗增益,即PH2Ochest增加量与Tre相应增加量的比值。受试者组间以及月经周期各阶段的VO2max均无差异。在P组中,q-L期出汗的直肠温度阈值(Tre,td)为37.85摄氏度,q-F期为37.60摄氏度(P<0.01),且与静息时的Tre存在显著差异。q-F期和q-L期运动期间,Tre、Tsk、Tb和fc的增加情况相似。在出汗动态或出汗增益方面均未观察到与月经周期阶段相关的差异。(摘要截短至250字)
Eur J Appl Physiol Occup Physiol. 1993
Eur J Appl Physiol Occup Physiol. 1999-7
J Appl Physiol (1985). 1985-12
J Appl Physiol (1985). 1985-12
J Appl Physiol (1985). 1992-2
Eur J Appl Physiol Occup Physiol. 1992
J Appl Physiol (1985). 1988-11
Am J Physiol Regul Integr Comp Physiol. 2005-5
Physiol Rev. 2022-10-1
J Int Soc Sports Nutr. 2021-4-1
Temperature (Austin). 2020-3-22
J Appl Physiol Respir Environ Exerc Physiol. 1981-1
J Physiol (Paris). 1982-8
J Appl Physiol. 1966-5
J Clin Endocrinol Metab. 1969-1
Annu Rev Physiol. 1973
J Appl Physiol (1985). 1985-12
J Appl Physiol (1985). 1985-12